Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Intermittent preventive treatment against malaria in infants in Gabon - A randomized, double-blind, placebo-controlled trial
Journal of Infectious Diseases, Volume 196, No. 11, Year 2007
Notification
URL copied to clipboard!
Description
Background. Intermittent preventive treatment aims to maximize the protective effects of malaria chemoprophylaxis while minimizing the deleterious effects. Methods. In Gabon, 1189 infants received either sulfadoxine- pyrimethamine (SP; 250 and 12.5 mg, respectively) or placebo at 3, 9, and 15 months of age. Children were actively followed-up until 18 months of age. Results. In the intention-to-treat population at 18 months of follow-up, 84 children (17%) in the SP group had ≥1 episode of anemia, versus 108 (21%) in the placebo group (protective efficacy, 22% [95% confidence interval {CI}, -1% to 40%]; P = .06). In the intervention group, there were 66 episodes during 485 person-years at risk, compared with 79 episodes during 497 years in the placebo group (protective efficacy, 17% [95% CI, -24% to 45%; P = .36). The effects were similar at 12 months of follow-up. The study drug was safe and well tolerated. Conclusions. The intervention was efficacious, producing a reduction in risk for anemia but a smaller effect against malaria. It is a valuable additional tool to control malaria in a highly vulnerable age group. Remaining important questions are currently being addressed in further studies. Trial registration. ClinicalTrials.gov identifier: NCT00167843. © 2007 by the Infectious Diseases Society of America. All rights reserved.
Authors & Co-Authors
Grobusch, Martín Peter
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Germany, Tubingen
Eberhard Karls Universität Tübingen
South Africa, Johannesburg
School of Pathology
Lell, Bertrand
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Germany, Tubingen
Eberhard Karls Universität Tübingen
Schwarz, Norbert Georg
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Gabor, Julian Justin
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Dörnemann, Jenny
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Poetschke, Marc
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Oyakhirome, Sunny
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Kießling, Georg C.
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Necek, Magdalena
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Längin, Matthias U.
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Klein Klouwenberg, Peter M.C.
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Klöpfer, Anna
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Naumann, Benjamin
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Altun, Handan
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Agnandji, Sélidji Todagbe M.
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Goesch, Julia
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Decker, Marieluise
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Ospina Salazar, Carmen Lucelly
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Supan, Christian
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Kombila, Ulrich Davy
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Borchert, Lea B.
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Köster, Kai B.
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Pongratz, Peter
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Adégnika, Ayôla Akim
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
von Glasenapp, Isabel
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Issifou, Saadou
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Kremsner, Peter G.
Gabon, Lambarene
Unité de Recherche Médicale, Albert Schweitzer Hospital
Germany, Tubingen
Eberhard Karls Universität Tübingen
Statistics
Citations: 83
Authors: 27
Affiliations: 3
Identifiers
Doi:
10.1086/522160
ISSN:
00221899
Research Areas
Disability
Infectious Diseases
Maternal And Child Health
Study Design
Randomised Control Trial
Cross Sectional Study
Cohort Study
Study Locations
Gabon